Clinical Trial

Study to Evaluate Safety and Activity of Inhaled TRL1068 in Healthy Volunteers

Not Yet Recruiting Phase 1
View on ClinicalTrials.gov →
Summary
This study in healthy volunteers will provide a basis for evaluation of inhaled TRL1068 as a first in human study, specifically, important safety, tolerability, and pharmacokinetic data.
Trial Details
NCT Number NCT07644195
Lead Sponsor Trellis Bioscience LLC
Collaborators: National Institute of Allergy and Infectious Diseases (NIAID)
Conditions Healthy Volunteer
Enrollment 14 participants
Start Date 2026-10
Primary Completion 2026-12 (estimated)
Study Completion 2026-12 (estimated)
Updated on ClinicalTrials.gov 2026-06-12